Skip to main content

Overview/Curriculum

The Pharmacy Residency Program at The Brooklyn Hospital Center has grown, both in size and in quality, since its inception in 2004.

By the numbers...

  • More than 100 alumni
  • 65% PGY-2 progression rate
  • 51.5% of PGY-1 alumni are board-certified pharmacotherapy specialists
  • 67% of ID PGY-2 alumni are board-certified pharmacotherapy specialists
  • 100% of Amb Care alumni are board-certified ambulatory care pharmacotherapy specialists

Our graduates choose careers across the spectrum of pharmacy, however, most either practice as a clinician or faculty member.

Purpose Statement

The purpose of our postgraduate year one (PGY-1) residency program is to develop accountability, practice patterns and habits, as well as expert knowledge, skills, attitudes and abilities in pharmacy practice. These programs will build upon Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification and eligible for postgraduate year two (PG-2) pharmacy residency training.

The purpose of our PGY-2 programs is to build upon the broad-based competencies achieved in a PGY-1 residency, deepening the resident's ability to provide care in the most complex of cases or in the support of care through practice leadership. Residents will have the opportunity to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients. Upon completion of this program, the resident should possess the competencies that enable attainment of board certification and qualify for a career path in their respective specialty area.

Our Department of Pharmacy Services supports the goals of our residency programs. The department is dynamic with a progressive clinical focus, staffed by 16 pharmacists, eight pharmacy residents, six interns, eight clinical coordinators, three clinical pharmacy educators, technicians, messengers and a dedicated management team. The department participates in all aspects of medication safety and dispensing with state-of-the-art computer systems and technology. Dispensing services are achieved with a balance of professional, technical and automated services, including a complete intravenous admixture service, TPN compounder and robotics.

Pharmacy Residency Program (PGY-1)

The PGY-1 Pharmacy Residency experience is intended to prepare the graduate to function as a pharmacotherapist within the typical health system. These experiential rotations will include:

  • Academia*
  • Adult Medicine*
  • Antimicrobial Stewardship*
  • Cardiology
  • Critical Care*
  • Emergency Medicine*
  • Geriatrics
  • HIV (Outpatient)
  • Infectious Diseases Consult Service
  • Pediatrics*
  • Pediatrics Intensive Care
  • Pharmacotherapist On-Call*
  • Pharmacotherapy Consult Service*
  • Pharmacy Practice Management*

*Required Rotations

Additionally, all residents participate in an Ambulatory Care experience to develop direct patient care skills. Collaborative Disease State Management Clinics include: Anticoagulation, Asthma (Adult/Pediatric), Heart Failure, Immunizations, Diabetes, Primary Care HIV, Smoking Cessation, HIV Patient Counseling, Medical Home, Pediatric Endocrine, Hepatitis C.

Pharmacy Residency Program (PGY-2) Ambulatory Care

The Ambulatory Care Pharmacy Residents (PGY-2) will have a strong emphasis in outpatient disease management clinics. Ten months will be spent in the outpatient setting.

Collaborative Disease State Management Clinics include:

  • Annual Wellness Visits
  • Anticoagulation
  • HIV Primary Care
  • Pharmacotherapy Clinics (which includes, but not limited to):
    • Adherence
    • Asthma
    • Cardiovascular Risk Reduction
    • Diabetes
    • Heart Failure
    • Hepatitis C
    • Hyperlipidemia
    • Hypertension
    • Immunizations
    • Smoking Cessation

As a component of the experience, the resident will have inpatient experience with a 4-week internal medicine rotation, 4-week Transitions of Care rotation (elective), and participating in the in-house on-call program. Residents will have the opportunity to respond to cardiac arrest, pediatric emergencies and rapid responses, as well as to provide drug information, toxicology consultation and pharmacokinetic dosing consults within the institution.

Ambulatory Care PGY-2s do not typically stay 24 hours in-house; rather their on-call experience is limited to a day shift approximately once every 2 to 3 weeks after an initial overnight orientation period.

Combined Pharmacy Residency (PGY-2)/Fellowship Program in Infectious Diseases 

The Infectious Diseases Pharmacy Residency (PGY-2)/Fellowship provides an environment of quality training in inpatient and outpatient infectious diseases pharmacotherapy, teaching, academia and research. Successful completion of the program prepares the individual to pursue career opportunities as a clinical specialist or faculty member at a college of pharmacy.

Year 1 (PGY-2 residency)

The PGY-2 ID residency develops proficiency in infectious diseases pharmacotherapy and practice management in both the inpatient and outpatient settings.

The following learning experiences are available throughout the PGY-2 year:

  • Foundations of Microbiology
  • Antimicrobial Stewardship (longitudinal)
  • Adult Inpatient ID Consult Service
  • Pediatric Inpatient ID
  • Critical Care
  • Emergency Medicine Antimicrobial Stewardship
  • ID in Immunocompromised Patients
  • HIV Clinic (longitudinal)
  • Research

As a component of the inpatient experience, the resident will be responsible for responding to cardiac arrest and pediatric emergencies, as well as for providing drug information, toxicology consultation and pharmacokinetic dosing consults within the institution as part of the program’s in-house on-call program. This will require the resident to remain in the hospital for a 24-hour period approximately once every 2 to 3 weeks, as well as a day shift every 3 weeks.

Year 2 (Fellowship)

The ID fellowship follows successful completion of the PGY-2 ID residency program. The fellowship program is sponsored through the Arnold & Marie Schwartz College of Pharmacy and Health Sciences (LIU Pharmacy).

Goals of the fellowship component include:

  • Build upon the knowledge and experience acquired during PGY-2 ID residency to provide evidence-based pharmacotherapy to diverse patient populations with infectious diseases
  • Develop skills and experience in research protocol development, data collection and analysis, and abstract and peer-reviewed manuscript writing
  • Function as a productive member of the interdisciplinary infectious diseases team and antibiotic stewardship program
  • Critically evaluate medical literature and apply the information to optimize patient care

The fellowship year will consist of the following experiences:

  • Clinical practice rotations (9 months)
    • Adult Inpatient ID Consult Service (6 months)
    • Antimicrobial Stewardship (3 months)
  • Clinical practice (longitudinal)
    • Precept pharmacy residents through the 24-hour Pharmacotherapy On-Call Program
  • Research (longitudinal)
    • Research conducted during the fellowship can be tailored towards the interests of the fellow (for example, clinical, in vitro, translational, etc.)
    • Serve as a co-investigator for PGY-1 and PGY-2 ID-related research projects
    • Submission of research to infectious diseases conferences for poster or platform presentations
    • Preparation of manuscript suitable for publication in peer-reviewed journals
  • Teaching and Academia (longitudinal)
    • Present at TBHC Pharmacotherapy Grand Rounds
    • Teach one or more didactic lectures at LIU
    • Participate in pharmacy resident orientation of ID-related services
    • Precept pharmacy residents and students on ASP or ID consult rotations
    • The fellow will serve as a mentor to the PGY-2 ID pharmacy resident

The research focus of the fellowship consists of:

  • Discovery of optimal antimicrobial regimens for infections caused by multidrug-resistant (MDR) bacteria, including carbapenem-resistant enterobacteriaceae (CRE), Pseudomonas aeruginosa, Acinetobacter baumannii, and methicillin-resistant Staphylococcus aureus
  • Identification of optimal beta-lactam pharmacodynamics/pharmacokinetic (PKPD) targets against MDR bacteria through in vitro and in silico modeling
  • Clinical translation of in vitro PKPD findings to advance therapeutic drug monitoring practices

These programs are a joint collaboration between LIU Pharmacy and The Brooklyn Hospital Center. The residency experience is designed to develop the resident into an independent practitioner with advanced expertise and an engaged faculty member with exposure to the three-legged stool of academia: teaching, service, scholarship.

Pharmacy Residency Program (PGY-2) ​Emergency Medicine 

The Pharmacy Resident in Emergency Medicine (PGY-2) will have significant clinical exposure to emergency medicine, critical care and academia with the following experiential rotations available:

  • Emergency Medicine Pharmacotherapy (32 weeks)
  • Medical Intensive Care (4 weeks)
  • Toxicology (4 weeks)
  • Pediatric Intensive Care/Emergency Medicine (4 weeks)
  • Emergency Medical Services (2 weeks)
  • Surgical Intensive Care (elective)
  • Infectious Diseases (elective)
  • Pharmacotherapist On-Call (longitudinal)
  • Resuscitative Care (longitudinal)
  • Disaster Preparedness (longitudinal)
  • Emergency Medicine Pharmacy Operations (longitudinal)
  • Research (longitudinal)
  • Academia (longitudinal)

​As a component of the inpatient experience, the resident will be responsible for responding to cardiac arrests, adult and pediatric medical emergencies, as well as to provide drug information, toxicology and pharmacokinetic consults within the institution as part of the program’s in-house on-call program. This will require the resident to remain in the hospital for a 24-hour period approximately once every 2 to 3 weeks and an on-call weekend day shift to cover emergency medicine, critical care, and infectious disease services. Each resident will also design and implement a longitudinal research project. The results of the research which will be presented at major clinical meetings.

Pharmacy Residency Program (PGY-2) ​Ambulatory Care

The Ambulatory Care Pharmacy Residents (PGY-2) will have a strong emphasis in outpatient disease management clinics. Ten months will be spent in the outpatient setting.

Collaborative Disease State Management Clinics include:

  • Annual Wellness Visits
  • Anticoagulation
  • HIV Primary Care
  • Pharmacotherapy Clinics (which includes, but not limited to):
    • Adherence
    • Asthma
    • Cardiovascular Risk Reduction
    • Diabetes
    • Heart Failure
    • Hepatitis C
    • Hyperlipidemia
    • Hypertension
    • Immunizations
    • Smoking Cessation

As a component of the experience, the resident will have inpatient experience with a 4-week internal medicine rotation, 4-week Transitions of Care rotation (elective), and participating in the in-house on-call program. Residents will have the opportunity to respond to cardiac arrest, pediatric emergencies, and rapid responses, as well as to provide drug information, toxicology consultation, and pharmacokinetic dosing consults within the institution.

Ambulatory Care PGY-2s do not typically stay 24 hours in-house, rather their on-call experience is limited to a day shift approximately once every 2 to 3 weeks after an initial overnight orientation period.